Industry | 2019.02.08
EpigeneticsRx Expands Team to Include Internationally Recognized Chief Scientific Officer
Dr. Kulvi Kaur, DPhil is the latest executive to join EpigeneticsRx as its Chief Scientific Officer. Dr. Kaur is internationally recognized for her work at Oxford on the application of disruptive technologies in the healthcare industry. She was recruited by the USA Biotechnology Industry on an ‘Einstein Visa’ as an Alien of Extraordinary Abilities for this work. She has over 20 years of DNA laboratory sequencing experience, clinical and diagnostic expertise in areas of oncology and toxicity, is a published researcher, and holds pharmacogenomics patents.
(PRWeb February 07, 2019)
Read the full story at https://www.prweb.com/releases/epigeneticsrx_expands_team_to_include_internationally_recognized_chief_scientific_officer/prweb16074172.htm
For more information, please visit
https://www.prweb.com/releases/epigeneti[...]ific_officer/prweb16074172.htm
